Los Angeles — Nutrition and longevity science company L-Nutra has been named a Top Vendor by Shortlister for the fourth quarter of 2025 in both Corporate Weight Management and Diabetes Management Programs, according to the company.
L-Nutra says the recognition underscores its position as a clinically validated, outcomes-driven nutrition provider for public and corporate health. Through its medical division, L-Nutra Health, the company partners with employers and payers to deliver programs with measurable biometrics, continuous monitoring, dietetic oversight and patented food-based nutrition technology.
Around the diabetes program, the company claims participants achieved average outcomes including a 67 % reduction in medication use, 22 lb average fat-focused weight loss while preserving muscle, a 1.4 % average A1C reduction and a 59 % reduction in insulin resistance. For the metabolic health program, the company says improvements extend to blood pressure, cholesterol, glucose and waist circumference via reduction in visceral fat.
L-Nutra also pointed to its research credentials, noting more than 40 clinical trials, 18 global university collaborations and over 200 patents worldwide. The company states its innovations originate from its founder, Professor Valter Longo and the University of Southern California’s Longevity Institute.
According to the company, the Shortlister designation reflects increasing demand from employers for health solutions that move beyond traditional wellness perks and deliver long-term outcomes at the organizational level.
